课题基金 / 基金详情

Targets of Reactive Lipid Species regulating DNA damage response and cell senescence

Targets of Reactive Lipid Species regulating DNA damage response and cell senescence
活性脂质种类调节 DNA 损伤反应和细胞衰老的靶标
批准号:
9517802
负责人:
Stephen J. Kron
金额:
$33.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30

项目摘要

项目成果

Stephen J. Kron的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Oxidative stress, ionizing radiation and chemotherapy agents including topoisomerase II (Top2) poisons such as etoposide can all promote therapy-induced senescence. The current paradigm is that DNA damage signaling is the common determinant of cellular senescence, whether induced by telomere erosion or chromosomal double strand breaks. However, our recent studies have implicated lipid peroxidation and resulting production of reactive lipid species (RLS) as key mediators of this pathway. This proposed work will examine Top2 as the critical target of RLS that promotes accelerated senescence. Here, we will apply biochemical and molecular tools to examine Top2 cysteine thiols as potential sites for modification by RLS such as 4-hydroxynonenal (4-HNE). We will determine if RLS modifications induce formation of the stable Top2-DNA cleaved complex (Top2cc), resulting in DNA double strand breaks and cellular senescence. To directly test whether DNA damage is indeed sufficient for senescence, we will apply Cas9 and promiscuous gRNAs as a source of "pure" double strand breaks. Further, combining Cas9-directed damage with RLS will provide a test of whether the two signals act in the same or distinct pathways. We will also pursue proteome- wide analysis of potential targets of RLS beyond Top2 that may regulate senescence. We will extend the work to evaluate the role of RLS in Top2 poisoning in vivo, using syngeneic tumors in mice. We will also use genetic depletion of senescent tumor cells formed after etoposide or radiation as a means to evaluate the relevance of therapy-induced senescence to tumor response to genotoxic therapy. This work may establish a new mechanism of action for etoposide and related chemotherapy agents as indirect topoisomerase poisons and pro-senescent drugs, with potential for impacts on their clinical use, both alone and in combination with other agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation
  • 批准号:
    10718390
  • 项目类别:
  • 资助金额:
    $47.24万
  • 财政年份:
    2023
  • 负责人:
    Stephen J. Kron
  • 依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
  • 批准号:
    10330483
  • 项目类别:
  • 资助金额:
    $57.67万
  • 财政年份:
    2021
  • 负责人:
    Stephen J. Kron
  • 依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
  • 批准号:
    10182630
  • 项目类别:
  • 资助金额:
    $60.2万
  • 财政年份:
    2021
  • 负责人:
    Stephen J. Kron
  • 依托单位:
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
  • 批准号:
    10547820
  • 项目类别:
  • 资助金额:
    $57.7万
  • 财政年份:
    2021
  • 负责人:
    Stephen J. Kron
  • 依托单位:
海外基金